Pumax Chemicals Profile
Key Indicators
- Authorised Capital ₹ 3.50 Cr
as on 24-10-2024
- Paid Up Capital ₹ 2.46 Cr
as on 24-10-2024
- Company Age 29 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 13.09 Cr
as on 24-10-2024
- Satisfied Charges ₹ 9.35 Cr
as on 24-10-2024
- Revenue -13.12%
(FY 2023)
- Profit -26.56%
(FY 2023)
- Ebitda 33.03%
(FY 2023)
- Net Worth 17.56%
(FY 2023)
- Total Assets 33.09%
(FY 2023)
About Pumax Chemicals
The Company is engaged in the Manufacturing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.50 Cr and a paid-up capital of Rs 2.46 Cr.
The company currently has active open charges totaling ₹13.09 Cr. The company has closed loans amounting to ₹9.35 Cr, as per Ministry of Corporate Affairs (MCA) records.
Piyush Maheshwari and Archana Maheshwari serve as directors at the Company.
- CIN/LLPIN
U25199TG1995PTC021313
- Company No.
021313
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Aug 1995
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Pumax Chemicals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Piyush Maheshwari  | Managing Director | 03-Aug-1995 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Archana Maheshwari | Whole-Time Director | 30-Nov-2006 | Current |
Financial Performance of Pumax Chemicals.
Pumax Chemicals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 13.12% decrease. The company also saw a substantial fall in profitability, with a 26.56% decrease in profit. The company's net worth Soared by an impressive increase of 17.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pumax Chemicals?
In 2023, Pumax Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 28 Dec 2022 | ₹12.96 Cr | Open |
Axis Bank Limited Creation Date: 27 Sep 2022 | ₹1.38 M | Open |
Axis Bank Limited Creation Date: 15 Oct 2016 | ₹0.50 M | Satisfied |
How Many Employees Work at Pumax Chemicals?
Pumax Chemicals has a workforce of 27 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pumax Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pumax Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
